Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Hypertension Treatment

Increase Awareness, Compliance and Adherence!

    • Cardiology
    • Congress Reports
    • Nephrology
    • RX
  • 2 minute read

Although many hypertensive patients perform regular blood pressure measurements at home, a large proportion of these patients – 51% in the SWISSHYPE study published in 2011 [1] – are inadequately treated or have a low blood pressure. does not reach the target blood pressure values. This is due on the one hand to a lack of compliance and adherence on the part of many patients, but often also to a therapy that is not optimally developed.

A team from the Institute of Family Medicine in Zurich has shown that blood pressure can be reduced with the help of a very simple and inexpensive intervention, namely the ab-
The results of the blood pressure test are impressive (syst. -14 mmHg, diast. -8 mmHg) [2, 3]. This is achieved on the one hand by increasing compliance and adherence and on the other hand by improving awareness on the part of both patients and physicians.

In practice, 24-hour blood pressure measurement is a cost-effective and time-efficient measure for diagnosing patients with high blood pressure. NICE guidelines recommend that all patients with a blood pressure >140/90 mmHg should have one performed first [4]. If the mean blood pressure in this measurement is 135-150/85-95 mmHg, it is recommended that only lifestyle measures be taken initially in patients with no end-organ damage and no increased cardiovascular risk (this can be determined using the AGLA risk calculator, for example, www.agla.ch). If the patient already has end-organ damage and/or an increased cardiovascular risk or if the values are >150/95 mmHg, drug treatment should be started in addition to lifestyle measures [4]. At the SGIM congress in Basel, Thilo Burkhard, MD, Basel, recommended that younger patients (<55 years) should always be started primarily with an angiotensin receptor blocker (ARB) or an ACE inhibitor and older patients with a calcium antagonist(Fig. 1) [4].

If monotherapy is not sufficient, ARB resp. ACE inhibitors and calcium antagonists are combined and only in a third step, if necessary, a diuretic is added [4]. According to Dr. Burkhard, most patients require combination therapy to achieve target blood pressure levels on a sustained basis. He therefore recommended that in patients with grade 2 hypertension or in the presence of end-organ damage – in addition to the lifestyle measures that always belong! – to consider a combination therapy already initially. Especially in patients who still need to take additional medications, fixed-dose combination preparations contribute to a significant improvement in adherence.

Source: “Hypertension Treatment in Family Practice – Good, but can it be better?” Satellite Symposium of A. Menarini AG, SGIM Congress, May 29-31, 2013, Basel.

Literature:

  1. Brenner R, et al: Swiss Med Wkly 2011; 141: w13169.
  2. Steurer-Stey C, et al: Trials 2010; 11: 38.
  3. Rosemann T: Results of the CoCo study. Paper presented at the SGIM Annual Meeting 2013.
  4. NICE: CG127, 2011. http://guidance.nice.org.uk/CG127
Autoren
  • Dr. med. Sabina M. Ludin
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Adherence
  • Blood pressure
  • Compliance
  • Diagnostics
  • Hypertension
  • Target blood glucose levels
  • Therapy
Previous Article
  • Roundtable discussion

Use of conventional NSAIDs and coxibs in high-risk patients.

  • Cardiology
  • Gastroenterology and Hepatology
  • Hematology
  • Interviews
  • RX
View Post
Next Article
  • Rheumatoid arthritis

How do current research findings influence future RA therapy?

  • Congress Reports
  • Rheumatology
  • RX
View Post
You May Also Like
View Post
  • 6 min
  • Itching in primary biliary cholangitis

When the skin becomes agony

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 2 min
  • TREATswitzerland Register

Evaluation of system therapies for AD

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 8 min
  • Cardiogenic shock - 2025 update

Between standardization, team processes and targeted cycle support

    • Cardiology
    • Education
    • Emergency and intensive care medicine
    • RX
    • Studies
View Post
  • 10 min
  • Collagenoses

Scleroderma – Current recommendations for diagnosis and therapy 2025

    • CME continuing education
    • Dermatology and venereology
    • General Internal Medicine
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Multiple sclerosis

Avoiding the nocebo trap with natalizumab biosimilars

    • Education
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • COPD and comorbidities

Exacerbation frequency is associated with cardiopulmonary disease burden

    • Education
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 12 min
  • Multiple myeloma

DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14

    • Congress Reports
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 9 min
  • Catheter ablation for atrial fibrillation 2025

Pulsed field versus radio frequency – where do we stand?

    • Cardiology
    • Education
    • RX
    • Studies
    • Surgery
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Consideration of the tumor microenvironment opens up new treatment options
  • 2
    What screening tools are helpful?
  • 3
    Scleroderma – Current recommendations for diagnosis and therapy 2025
  • 4
    Advantages of topical pharmacotherapy – Update 2025
  • 5
    Ritual, party or new therapy? Psychedelics and more: clinically illuminated

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.